Advanced search
Publication Cover
Journal of Microencapsulation
Micro and Nano Carriers
Volume 20, 2003 - Issue 4
Submit an article Journal homepage
153
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part I: Evaluation of different techniques for the encapsulation of Pamidronate di-sodium salt

U. Weidenauer Ciba Vision, Grenzstraße 10, 8180 Bülach, Switzerland
,
D. Bodmer Department of Pharmaceutics and Biopharmacy, Philipps-University, Ketzerbach 63, 35032 Marburg, Germany; Novartis Pharma Ltd., 4002 Basel, Switzerland
&
T. Kissel Department of Pharmaceutics and Biopharmacy, Philipps-University, Ketzerbach 63, 35032 Marburg, GermanyCorrespondence[email protected]
Pages 509-524 | Received 11 Jun 2003, Accepted 11 Jun 2003, Published online: 11 Jun 2003

  • DALEY-YATES, P. T., DODWELL, D. J., PONGCHAIDECHA, M., COLEMAN, R. E. and HOWELL, A., 1991, The clearance and bioavailability of pamidronate in patients with breast cancer and bone metastases. Calcified Tissue International, 49, 433-435.
  • FITTON, A. and McTAVISH, D., 1991, Pamidronate--a review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs, 41, 289-318.
  • FLEISCH, H., 1997, Bisphosphonates: mechanisms of action and clinical use in osteoporosis--an update. Hormone and Metabolic Research, 29, 145-150.
  • BOOMER, D., KISSEL, T. and TRAECHSLIN, E., 1992, Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems. Journal of Controlled Release, 21, 129-138.
  • TSAI, D. C., HOWARD, S. A., HOGAN, T. F., MALANGA, C. J., KANDZARI, S. J. and MA, J. K. H., 1986, Preparation and in vitro evaluation of polylactic acid-mitomycin C microcapsules. Journal of Microencapsulation, 3, 181-193.
  • UCHIDA, T., YAGI, A., ODA, Y. and GOTO, S., 1996, Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method. Journal of Microencapsulation, 13, 509-518.
  • WEIDENAUER, U., 2000, Feasibility study for the microencapsulation of pamidronatedisodium using D,L-poly(lactide-co-glycolide acid-glucose): evaluation of different techniques and devices. PhD Thesis, Institut für Pharmazeutische Technologie, Philippe-Universität, Marburg/Lahn.
  • WEIDENAUER, U., BODMER, D. and KISSEL, T., 2000, Microencapsulation of bisphosphonates into biodegradable polymers. 3rd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Berlin.
  • ALEX, R. and BODMEIER, R., 1990, Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. Journal of Microencapsulation, 7, 347-355.
  • BODMEIER, R. and McGINITY, J. W., 1987, The preparation and evaluation of drugcontaining poly(DL-lactide) microspheres formed by the solvent evaporation method. Pharmaceutical Research, 4, 465-471.
  • VISWANATHAN, N. B., THOMAS, P. A., PANDIT, J. K., KULKARNI, M. G. and MASHELKAR, R. A., 1999, Preparation of non-porous microspheres with high entrapment efficiency of proteins by a (water-in-oil)-in-oil emulsion technique. Journal of Controlled Release, 58, 9-20.
  • BRICH, Z. and KISSEL, T., 1984, Polyolester, deren Herstellung und Verwendung, CH 672 133 AS.
  • CROTTS, G. and PARK, T. G., 1995, Preparation of porous and nonporous biodegradable polymeric hollow microspheres. Journal of Controlled Release, 35, 91-105.
  • FLESCH, G. and HAUE, S. A., 1989, Determination of the bisphosphonate pamidronate disodium in urine by pre-column derivatization with fluorescamine, high-performance liquid chromatography and fluorescence detection. Journal of Chromatographie, 489, 446-451.
  • GOLOMB, G., 1987, Controlled release of diphosphonates from synthetic polymers to inhibit calcification. Journal of Biomaterials Applications, 2, 266-289.
  • KISSEL, T., KONEBERG, R., HILBERT, A. K. and HUNGERER, K. D., 1997, Microencapsulation of antigens using biodegradable polyesters: facts and phantasies. Behring Institute Mitteilungen, 98, 172-183.
  • FLESCH, G., TOMINAGA, N. and DEGEN, P., 1991, Improved determination of the bisphosphonate pamidronate disodium in plasma and urine by pre-column derivatization with fluorescamine, high-performance liquid chromatography and fluorescence detection. Journal of Chromatography, 568, 261-266.
  • GEZE, A., VENIER-JULIENNE, M. C., MATHIEU, D., FILMON, R., PHAN-TAN-LUU, R. and BENOIT, J. P., 1999, Development of 5-iodo-2'-deoxyuridine milling process to reduce initial burst release from PLGA microparticles. International Journal of Pharmaceutics, 178, 257-268.
  • GOLOMB, G., LANGER, R., SCHOEN, F. J., SMITH, M. S., CHOI, Y. M. and LEVY, R. J., 1986, Controlled release of diphosphonate to inhibit bioprosthetic heart valve calcification: dose-response and mechanistic studies. Journal of Controlled Release, 4, 181-194.
  • TAKADA, S., KUROKAWA, T. and IWASA, S., 1995, Sustained-release preparation. European Patent Application O 709 085 Al.
  • TAKADA, S., KUROKAWA, T., MIYAZAKI, K., IWASA, S. and OGAWA, Y., 1997, Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres. Pharmaceutical Research, 14, 1146-1150.
  • GUTTERIDGE, D. H., RETALLACK, R. W., WARD, L. C., STUCKEY, B. G. A., STEWART, G. O., PRINCE, R. L., KENT, G. N., BHAGAT, C. I., PRICE, R. I., TOMPSON, R. I. and NICHOLSON, G. C., 1996, Clinical, biochemical, hematologic, and radiographie responses in Paget's disease following intravenous pamidronate disodium: a 2-year study. Bone, 10, 387-394.
  • HULTBORN, R., GUNDERSEN, S., RYDEN, S., HOLMBERG, E., CARSTENSEN, J., WALLGREN, U. B., KILLANY, S., ANDREASSEN, L., CARLSSON, G., FAHL, N., HATSCHEK, T., SOMMER, H. H., HESSMAN, Y., HORNMARK-STENSTAM, B., JOHNSBORG, S., KLEPP, R., LAINO, R., NIKLASSON, L. G., RUDENSTAM, C. M., SUNDBECK, A., SODERBERG, M. and TEJLER, G., 1999, Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter study. Anticancer Research, 19, 3383-3392.
  • JALIL, R. and NIXON, J. R., 1989, Microencapsulation using poly(L-lactic acid) I: Microcapsule properties affected by the preparative technique. Journal of Microencapsulation, 6, 473-484.
  • KISSEL, T., BRICH, Z., BANTLE, S., LANCRANJAN, L, NIMMERFALL, F. and VIT, P., 1991, Parenteral depot-systems on the basis of biodegradable polyesters. Journal of Controlled Release, 16, 27-42.
  • IWATA, M., TANAKA, T., NAKAMURA, Y. and McGINITY, J. W., 1998, Selection of the solvent system for preparation of poly(D,L-lactic-co-glycolic acid) microspheres containing tumor necrosis factor-alpha. International Journal of Pharmaceutics, 160, 145-156.
  • LEWIS, D. H., 1990, Controlled release of bioactive agents from lactide/glycolide polymers. In: Biodegradable Polymers as Drug Delivery Systems, edited by M. Chasin and R. Langer (New York: Marcel Dekker), pp. 1-41.
  • LICH, A., 1991, Intravengös applizierfähige O/W-Emulsionen als Vehikel für schlechtlüsliche mikronisierte Wirksubstanzen. PhD Thesis Institut für Pharmazeutische Technologie, Philippe-Universität, Marburg/Lahn, p. 189.
  • OH, I., KANG, Y.-G., LEE, Y.-B., SHIN, S.-C. and KIM, C.-K., 1998, Prolonged release of tegafur from S/O/W multiple emulsion. Drug Development and Industrial Pharmacy, 24, 889-894.
  • PATASHNIK, S., RABINOVICH, L. and GOLOMB, G., 1997, Preparation and evaluation of chitosan microspheres containing bisphosphonates. Journal of Drug Targeting, 4, 371-380.
  • OGAWA, Y., YAMAMOTO, M., TAKADA, S., OKADA, H. and SHIMAMOTO, T., 1988, Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer. Chemical & Pharmaceutical Bulletin, 36, 1502-1507.
  • PENNANEN, N., LAPINJOKI, S., URTTI, A. and MÖNKKÖNEN, J., 1995, Effect of liposomal and free bisphosphonates on the IL-1β, IL-6 and TNF-a secretion from RAW 264 cells in vitro. Pharmaceutical Research, 12, 916-922.
  • PISTEL, K.-F. and KISSEL, T., 2000, Effects of salt addition on the microencapsulation of proteins using W/O/W double emulsion technique. Journal of Microencapsulation, 17, 467-483.
  • RUSSELL, R. G. G., CROUCHER, P. I. and ROGERS, M. J., 1999, Bisphosphonates: pharmacology, mechanisms of action and clinical uses. Osteoporosis International Supplement, 2, S66-S80.
  • SPENLEHAUER, G., VEILLARD, M. and BENOIT, J. P., 1986, Formation and characterization of cisplatin loaded poly(D,L-lactide) microspheres for chemoembolization. Journal of Pharmaceutical Sciences, 75, 750-755.
  • FISTEL, K. F., BITTNER, B., KOLL, H., WINTER, G. and KISSEL, T., 1999, Biodegradable recombinant human Erythropoietin loaded microspheres prepared from linear and star-branched block copolymers: Influence of encapsulation technique and polymer composition on particle characteristics. Journal of Controlled Release, 59, 309-325.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.